(Q24292700)
Statements
ERK5 is targeted to myocyte enhancer factor 2A (MEF2A) through a MAPK docking motif (English)
0 references
1 August 2004
0 references
381
0 references
Pt 3
0 references
693-9
0 references
scientific article